Related Experiment Video
Updated: Jun 26, 2026
10:31
Lymphocyte Isolation from Human Skin for Phenotypic Analysis and Ex Vivo Cell Culture
Published on: April 8, 2016
B-cell-directed therapy for inflammatory skin diseases.
Angela Nagel1, Michael Hertl, Rüdiger Eming
1Department of Dermatology and Allergology, Philipps University, Marburg, Germany.
The Journal of Investigative Dermatology
|January 17, 2009
Summary
B cells are increasingly recognized as key players in autoimmune skin diseases, not just antibody producers. Targeting B cells offers promising new therapeutic strategies for inflammatory and autoimmune skin disorders.
Area of Science:
- Immunology
- Dermatology
- Autoimmunity
Background:
- Understanding of inflammatory dermatoses and autoimmune skin disorders has advanced.
- New psoriasis treatments highlight the role of immune cells and cytokines in chronic inflammation.
Purpose of the Study:
- To explore the evolving understanding of B cell involvement in autoimmune skin diseases.
- To discuss the potential of B cell-targeted therapies.
Main Methods:
- Review of recent investigations into inflammatory skin diseases.
- Analysis of B cell function in autoimmunity.
- Consideration of clinical data from B cell depletion therapies.
Main Results:
- B cells are implicated in the pathogenesis of autoimmune blistering disorders, collagen vascular diseases, and atopic dermatitis.
- B cells may be as crucial as T cells in these conditions.
- B cell depletion has shown clinical benefits in related autoimmune diseases like rheumatoid arthritis.
Conclusions:
- The role of B cells in autoimmune skin diseases extends beyond autoantibody production.
- B cell-targeted therapies are a promising area for future research and treatment.
- Further translational and clinical studies are needed to define B cell contributions precisely.
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...